Iradimed Co Total Liabilities
Iradimed Co total liabilities. Based on the latest financial reports, Iradimed Co (IRMD) has total liabilities worth $13.23 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Iradimed Co liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Iradimed Co (2012–2025)
Total liabilities of Iradimed Co from 2012 to 2025. This chart illustrates how Iradimed Co's total liabilities have evolved over time, based on quarterly financial data.
Iradimed Co Competitors by Total Liabilities
The table below lists competitors of Iradimed Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Medartis Holding AG
SW:MED
|
Switzerland | CHF328.18 Million |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
USA | $280.60 Million |
|
Drägerwerk AG & Co. KGaA (pref)
F:DRW3
|
Germany | €1.51 Billion |
|
Anhui Water Resources Development Co Ltd
SHG:600502
|
China | CN¥194.79 Billion |
|
Dongwon Ind
KO:006040
|
Korea | ₩3.99 Trillion |
|
Suzhou Victory Precision Manufacture Co Ltd
SHE:002426
|
China | CN¥4.18 Billion |
|
China Railway Tielong Container Logistics Co Ltd
SHG:600125
|
China | CN¥2.57 Billion |
|
Paradise Co. Ltd
KQ:034230
|
Korea | ₩1.78 Trillion |
Liability Composition Analysis (2012–2025)
This chart breaks down Iradimed Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Iradimed Co (IRMD) total assets.
Liquidity & Leverage Metrics
Iradimed Co Total Liabilities Ratios Explained
Iradimed Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iradimed Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iradimed Co (2012–2025)
The table below shows the annual total liabilities of Iradimed Co from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $14.16 Million | +23.04% |
| 2024-12-31 | $11.51 Million | -44.51% |
| 2023-12-31 | $20.74 Million | +75.12% |
| 2022-12-31 | $11.84 Million | +10.58% |
| 2021-12-31 | $10.71 Million | +10.59% |
| 2020-12-31 | $9.68 Million | -13.59% |
| 2019-12-31 | $11.20 Million | +72.47% |
| 2018-12-31 | $6.50 Million | +6.82% |
| 2017-12-31 | $6.08 Million | +14.63% |
| 2016-12-31 | $5.31 Million | +60.23% |
| 2015-12-31 | $3.31 Million | +36.88% |
| 2014-12-31 | $2.42 Million | +54.66% |
| 2013-12-31 | $1.56 Million | -32.99% |
| 2012-12-31 | $2.33 Million | -- |
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more